Competing risk analysis of events 10 years after revascularization

References

• Bravata DM, McDonald KM, Gienger AL, Sundaram V, Perez MV, Varghese R, . Comparative effectiveness of percutaneous coronary interventions and coronary artery bypass grafting for coronary artery disease. Comparative Effectiveness Review No. 9. (Prepared by Stanford-UCSF Evidence-based Practice Center under Contract No. 290-02-0017.) Rockville, MD: Agency for Healthcare Research and Quality. October 2007. Available from: http://www.effectivehealthcare.ahrq.gov/reports/final.cfm
   Google Scholar
• Sergeant P, Blackstone E, Meyns B, K.U. Leuven Coronary Surgery Program. Validation and interpretation of the influence of procedural variables on early and late survival after CABG. Eur J Cardiothorac Surg. 1997;12:1–19.
   PubMed Web of Science ®Google Scholar
• Mack MJ. Clinical trials versus registries in coronary revascularization: Which are more relevant? Curr Opin Cardiol. 2007;22:524–8.
   PubMed Web of Science ®Google Scholar
• Van Domburg RT, Foley DP, Breeman A, der Herwerden LA, Serruys PW. Coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. 20 year outcome. Eur Heart J. 2002;23:543–9.
   PubMed Web of Science ®Google Scholar
• Weintraub WS, Clemens Jr. SD, Crisco V-T, Guyton RA, Craver JM, Jones EL, . Twenty-year survival after coronary artery surgery: An institutional perspective from Emory university. Circulation. 2003:107:1271–77.
   PubMed Web of Science ®Google Scholar
• Ford ES, Ajani UA, Croft JB, Critchley JA, Critchley JA, Labarthe DR, . Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. NEJM. 2007;356: 2388–98.
   PubMed Web of Science ®Google Scholar
• Teirstein PS. The duelling hazards of incomplete revascularization and incomplete data. Circulation. 2006;113:2380–2.
   PubMed Web of Science ®Google Scholar
• Booth J, Clayton T, Pepper J, Nugara F, Flather M, Sigwart U, . Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease. Six-year follow-up from the stent or surgery trial (SoS). Circulation. 2008;118:381–8.
   PubMed Web of Science ®Google Scholar
• Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959–69.
   PubMed Web of Science ®Google Scholar
• Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research. Time for a reassessment? J Am Coll Cardiol. 1999;34:618–20.
   PubMed Web of Science ®Google Scholar
• Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, . Clinical end points in coronary stent trials: A case for standardized definitions. Circulation. 2007;115: 2344–51.
   PubMed Web of Science ®Google Scholar
• Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Statist Med. 1999;18: 695–706.
   PubMed Web of Science ®Google Scholar
• Pintilie M. Competing risks. A practical perspective. Chichester: John Wiley & Sons Ltd.; 2006.
   Google Scholar
• Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S. Death without prior appropriate implantable cardioverter-defibrillator therapy. A competing risk study. Circulation. 2008;117:1918–26.
   PubMed Web of Science ®Google Scholar
• Albertia C, Metivier F, Landaisc P, Thervet E, Legendre C, Chevret S. Improving estimates of event incidence over time in populations exposed to other events. Application to three large databases. J Clin Epidemiol. 2003;56:536–45.
   PubMed Web of Science ®Google Scholar
• Gooley TA, Leisenring W, Crowley J, Storer B. Why Kaplan-Meier fails and cumulative incidence succeeds when estimating failure probabilities in the presence of competing risks. Handbook of statistics in clinical oncology. New York: Marcel Dekker; 2001. 513–23.
   Google Scholar
• Ong AT, Serruys PW. Complete revascularization: Coronary artery bypass graft surgery versus percutaneous coronary intervention. Circulation. 2006;114:249–55.
   PubMed Web of Science ®Google Scholar
• Hannan EL, Racz R, Holmes DR, King SB III, Walford G, Ambrose JA, . Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation. 2006;113:2406–12.
   PubMed Web of Science ®Google Scholar
• Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper D, Burton JR. Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol. 1996;28:616–26.
   PubMed Web of Science ®Google Scholar
• PREVENT IV investigators. Efficacy and safety of edifogilide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: A randomized controlled trial. JAMA. 2005; 294:2446–54.
   PubMed Web of Science ®Google Scholar
• Vikenes K, Andersen KS, Melberg T, Farstad M, Nordrehaug JE. Long-term prognostic value of creatine kinase-myocardial band mass after cardiac surgery in low-risk patients with stable angina. Cardiology. 2009;113:122–31.
   PubMed Web of Science ®Google Scholar
• Steuer J, Granath F, de Faire U, Ekbom A, Ståhle E. Increased risk of heart failure as a consequence of perioperative myocardial injury after coronary artery bypass grafting. Heart. 2005;91:754–8.
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Sopko G, De Luca L, Velazquez EJ, Parker JD, Binkley PE, . Navigating the crossroads of coronary artery disease and heart failure. Circulation. 2006;114: 1202–13.
   PubMed Web of Science ®Google Scholar
• Canty JM, Jr. Metabolic and functional consequences of ischemia. Libby P. Braunwald's heart disease. 8th. Ch. 48. Philadelphia: Saunders; 2007.
   Google Scholar
• Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, . Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: A meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation. 2008;118:1146–54.
   PubMed Web of Science ®Google Scholar
• Ebbing M, Bleie Ø, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, . Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: A randomized controlled trial. JAMA. 2008;300:795–804.
   PubMed Web of Science ®Google Scholar
• Mølstad P. Survival after percutaneous coronary intervention and coronary artery bypass grafting in a single centre. Scand Cardiovasc J. 2007;41:214–20.
   PubMed Web of Science ®Google Scholar
• Trikalinos TA, Alsheikh-Ali AA, Tatsioni AA, Nallamothu BK, Kent DM. Percutaneous coronary interventions for non-acute coronary artery disease: A quantitative 20-year synopsis and a network meta-analysis. Lancet. 2009;373:911–8.
   PubMed Web of Science ®Google Scholar